The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ADMA Biologics, Inc(NASDAQ:ADMA) 
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of pr...
Website: http://www.admabiologics.com
Founded: 2007
Full Time Employees: 313
CEO: Adam Grossman
Sector: Healthcare
Industry: Biotechnology
ADMA Biologics Days Payable Outstanding ttm (DPO)
ADMA Biologics Days Receivable Outstanding ttm (DSO)
ADMA Biologics Days Inventory Outstanding ttm (DIO)
ADMA Biologics Op Cashflow Per Share ttm
ADMA Biologics Free Cashflow Per Share ttm
ADMA Biologics Cash Per Share ttm
ADMA Biologics P/S ratio ttm
ADMA Biologics (GAAP) P/E ratio ttm
ADMA Biologics P/B ratio ttm
No extra charts and metrics for this ticker.